A Study to Assess IPN01194 When Administered Alone in Adults With Advanced Solid Tumours

NCT06305247 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

220

Enrollment

INDUSTRY

Sponsor class

Conditions

Melanoma
Head and Neck Squamous Cell Carcinoma
Pancreatic Ductal Adenocarcinoma
Colorectal Cancer
Solid Tumor

Interventions

DRUG: IPN01194
DRUG: IPN01194

Sponsor

Ipsen